Почетна › Алцхајмерова болест › Džordžija
Kliničke studije za Алцхајмерова болест u državi Džordžija
29 studija za Алцхајмерова болест traži učesnike na lokacijama u državi Džordžija.
Gradovi u državi Džordžija
Zvanični tekst studije (na engleskom)
Adaptango Performance PRocess for Older Adults Community reHabilitation
- Emory University, Executive Park, Wesley Woods, Atlanta
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07824128A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Augusta
- Clinical Site, Snellville
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2611, Atlanta
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 12. 11. 2026. · NCT06937229A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Alzheimer's Research and Treatment Center - Columbus, Columbus
Тражи се учесникФаза 3
Узраст од 55 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07717411Flutemetamol F 18 Injection Formulation Comparison
- Center for Advanced Research & Education LLC dba Flourish Research Gainesville, Gainesville
Тражи се учесникФаза 2
Узраст од 50 до 110 · Оба пола · Ажурирано 5. 11. 2026. · NCT07873463A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
- Accel Research Sites - NeuroStudies Clinical Research Unit, Decatur
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 85 · Оба пола · Ажурирано 5. 11. 2026. · NCT07787169A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Agile Clinical Research Trials, LLC, Atlanta
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 3. 11. 2026. · NCT07011745A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- CenExeli Research LLC, Savannah
Тражи се учесникФаза 2
Узраст 55 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06540833A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel iResearch, LLC (CenExel iRA), Decatur
Тражи се учесникФаза 1
Узраст од 50 до 85 · Оба пола · Ажурирано 29. 10. 2026. · NCT06297590A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Center for Advanced Research & Education, Gainesville
- North Georgia Clinical Research, Woodstock
Тражи се учесникФаза 3
Узраст 55 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07602582A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Center for Advanced Research & Education, Gainesville
Тражи се учесникФаза 3
Узраст од 60 до 85 · Оба пола · Ажурирано 27. 10. 2026. · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Agile Clinical Research Trials, LLC, Atlanta
Тражи се учесникФаза 3
Узраст од 55 до 90 · Оба пола · Ажурирано 27. 10. 2026. · NCT06585787A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
- Accel Research Sites - NeuroStudies Clinical Research Unit, Decatur
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 85 · Оба пола · Ажурирано 22. 10. 2026. · NCT07787182A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- CenExel iResearch, LLC ( Site 1015), Decatur
Тражи се учесникФаза 2
Узраст од 50 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07033494Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Grady Memorial Hospital, Atlanta
- Alzheimer's Research and Treatment Center - Columbus, Columbus
- Accel Research Sites-NeuroStudies, Decatur
- и још 2
Тражи се учесникФаза 3
Узраст од 50 до 90 · Оба пола · Ажурирано 19. 10. 2026. · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Accel Research - NeuroStudies, Decatur
Тражи се учесникФаза 4
Узраст 50 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07633470Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Columbus Memory Center, Columbus
- Center for Advanced Research & Education Flourish-Gainesville, Gainsville
Тражи се учесникФаза 2
Узраст од 55 до 80 · Оба пола · Ажурирано 7. 10. 2026. · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- CenExel iResearch, LLC, Decatur
- CenExel iResearch, LLC, Savannah
Тражи се учесникФаза 2
Узраст од 55 до 90 · Оба пола · Ажурирано 6. 10. 2026. · NCT06808984A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
- Local Institution - 0004, Decatur
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 80 · Оба пола · Ажурирано 24. 9. 2026. · NCT07780383AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Alzheimer's Research and Treatment Center (Columbus), Columbus
Тражи се учесникФаза 1
Узраст од 65 до 80 · Оба пола · Ажурирано 21. 8. 2026. · NCT07158905Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Emory University School of Medicine, Atlanta
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 8. 2026. · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Emory University, Atlanta
Тражи се учесникФаза 2/3Здраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05552157Moving Yourself in Space and Time: MYSTIC
- Emory University, Executive Park, Wesley Woods, Atlanta
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 13. 7. 2026. · NCT07697664A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Atlanta Center of Medical Research, Atlanta
- CenExel iResearch, LLC (CenExel iRA), Decatur
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 45 до 85 · Оба пола · Ажурирано 4. 6. 2026. · NCT06657768Inspiring Seniors Towards Exercise Promotion to Protect Cognition
- Emory University, Atlanta
Тражи се учесникЗдраве особе су добродошле
Узраст 65 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT06496425Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
- Emory Rehabilitation Hospital, Atlanta
Тражи се учесник
Узраст од 50 до 90 · Оба пола · Ажурирано 2. 3. 2026. · NCT06484244Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)
- Reminiscent, Valdosta
Тражи се учесник
Узраст од 65 до 90 · Оба пола · Ажурирано 4. 2. 2026. · NCT05205980A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Wellstar MCG Hospital, Neurology Memory Clinic, Augusta
Тражи се учесникФаза 1
Узраст од 65 до 85 · Оба пола · Ажурирано 7. 1. 2026. · NCT07218081Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.